Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00053144
Status:
COMPLETED
Last Update Posted:
2011-03-08
First Post:
2003-01-27
Brief Title:
Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia
Sponsor:
Roswell Park Cancer Institute
Organization:
Roswell Park Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
Keywords:
| Name | View |
|---|---|
| adult acute promyelocytic leukemia M3 | View |
| recurrent adult acute myeloid leukemia | View |
| Philadelphia chromosome positive chronic myelogenous leukemia | View |
| secondary acute myeloid leukemia | View |
| blastic phase chronic myelogenous leukemia | View |
| relapsing chronic myelogenous leukemia | View |
| adult acute monocytic leukemia M5b | View |
| adult acute erythroid leukemia M6 | View |
| adult acute megakaryoblastic leukemia M7 | View |
| adult acute minimally differentiated myeloid leukemia M0 | View |
| adult acute myeloblastic leukemia with maturation M2 | View |
| adult acute myeloblastic leukemia without maturation M1 | View |
| adult acute myelomonocytic leukemia M4 | View |
| adult acute monoblastic leukemia M5a | View |